JMAC Enterprises’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$497K Buy
+4,800
New +$428K 0.08% 98
2024
Q2
Sell
-4,544
Closed -$362K 175
2024
Q1
$362K Sell
4,544
-503
-10% -$38.4K 0.07% 136
2023
Q4
$399K Sell
5,047
-3,800
-43% -$270K 0.09% 129
2023
Q3
$618K Sell
8,847
-981
-10% -$69.5K 0.15% 111
2023
Q2
$679K Buy
9,828
+1,470
+18% +$105K 0.17% 103
2023
Q1
$621K Buy
8,358
+3,031
+57% +$254K 0.16% 106
2022
Q4
$496K Buy
5,327
+1,479
+38% +$143K 0.14% 119
2022
Q3
$367K Buy
+3,848
New +$381K 0.1% 137

Other funds holding CVS

JMAC Enterprises's CVS Position: Q2 2026 in Review

JMAC Enterprises opened a new position in CVS Health (CVS) in Q2 2026: 4,800 shares worth $497K. The stake represents 0.08% of the portfolio and ranks #98 among its holdings. This is a return to the name: JMAC Enterprises previously reported a position in CVS as recently as Q1 2024.

JMAC Enterprises first reported a position in CVS in Q3 2022 and has held it in 8 quarters since. The position peaked at $679K in Q2 2023. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • JMAC Enterprises held 4,800 shares of CVS Health worth $497K as of Q2 2026.
  • CVS Health was a new JMAC Enterprises position in Q2 2026.
  • CVS Health made up 0.08% of JMAC Enterprises's portfolio in Q2 2026, its #98 holding.
  • JMAC Enterprises first reported a position in CVS Health in Q3 2022 and has held it in 8 quarters since.
  • JMAC Enterprises's CVS Health position peaked at $679K in Q2 2023.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on JMAC Enterprises's 13F filing for Q2 2026, filed 28 Jul 2026.